| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Organogenesis Holdings Inc.
13D/A
ORGO · 68621F102
|
17.6% |
6/26/2025
Event 6/24/2025
|
||||
| Alan A. Ades | 17.6% | |||||
| Albert Erani | 14.1% | |||||
| Glenn H. Nussdorf | 9.4% | |||||
| Dennis Erani | 7.9% | |||||
| Starr Wisdom | 0% | |||||
| Organo PFG LLC | 6.5% | |||||
| Organo Investors LLC | 2.2% | |||||
| Alan Ades 2014 GRAT | 2.4% | |||||
| Albert Erani Family Trust dated 12/29/2012 | 0% | |||||
| Dennis Erani 2012 Issue Trust dated 12/20/12 | 6.6% | |||||
| GN 2016 Family Trust u/a/d August 12, 2016 | 0.7% | |||||
| GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 | 7.0% | |||||
| RED Holdings, LLC | 5.3% | |||||
| Josette Ades | 6.4% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.